| USD millions | FY2024 | FY2025 | TTM |
|---|---|---|---|
| Revenue | 67.6 | 117.7 | 167.6 |
| Cost of revenue | 44.1 | 45.3 | 71.8 |
| Gross profit | 23.4 | 72.4 | 95.8 |
| Research & development | 24.8 | 28.9 | 33.6 |
| Operating expenses | 58.1 | 75.5 | 162.3 |
| Operating income | (34.7) | (3.1) | (19.2) |
| Interest expense | 0.2 | 0.3 | 2.5 |
| Interest income | 5.8 | 3.4 | 5.2 |
| Pre-tax income | (29.0) | (4.1) | (28.1) |
| Income tax | 0.0 | (6.7) | (6.5) |
| Net income | (29.0) | 2.3 | (21.6) |
| EPS, basic (per share) | (0.34) | 0.00 | (1.18) |
| EPS, diluted (per share) | (0.34) | 0.00 | (1.18) |
| EBITDA | (9.5) | 20.5 | 9.8 |
| Depreciation & amortization | 25.2 | 23.6 | — |
| Weighted average shares (shares) | 93,084,412 | 93,084,412 | — |
| Weighted average diluted shares (shares) | 93,084,412 | 93,084,412 | — |
| Gross margin | 34.7% | 61.5% | 57.2% |
| Operating margin | −51.3% | −2.6% | −11.5% |
| Net margin | −42.9% | 1.9% | −12.9% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.